Cystic fibrosis trials in Sweden

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Sweden
  Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis

  Where

  Goteborg, Huddinge

  Age

  18 years and over

  People

  80 worldwide

  Run by

  Vertex Pharmaceuticals Inc.

  See details and how to join2025-523400-72-00 · EU 2025-523400-72-00
• Phase 3Enrolling by invitation
  Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older

  Where

  Gothenburg, Huddinge

  Age

  1 year to 17 years

  People

  174 worldwide

  Run by

  Vertex Pharmaceuticals Incorporated

  See details and how to joinNCT05844449 · EU 2022-503081-74-00
• No phaseTaking people
  VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients

  Where

  Gothenburg

  Age

  Up to 25 years

  People

  550

  Run by

  Sahlgrenska University Hospital

  See details and how to joinNCT07202910
• No phaseTaking people
  CFTR Modulators in Pregnancy and Postpartum

  Where

  Stockholm

  Age

  Up to 50 years

  People

  75

  Run by

  Region Stockholm

  See details and how to joinNCT06302270